Endothelial Fibrinolytic Activity in Hypercholesterolemic and Diabetic Rats;Effect of Stanozolol,Streptozotocin,Dexamethasone and Hypophysectomy

Abstract

In genetically hypercholesterolaemic rats (RICO) the intimal plasminogen activator activity (PAA) at the nonbranching regions of the aorta, but not at the branching regions, was markedly lower than in controls.

In alloxan-induced diabetes in rats, the pattern of changes in tissue PAA was different in different tissues.

The anabolic steroid stanozolol induced in male rats a dose and time dependent increase in the tissue PAA; this increase was varying from one tissue to another.

The antibiotic streptozotocin, at a diabetogenic dose, induced a 200% increase in the intimal PAA of the aorta in RICO rats and by 100% in controls (normal rats) ten weeks after a single injection. Administration of dexamethasone in normal rates 24 hours and 3 hours before streptozotocin injection prevented the enhancement of PAA. However, administration of dexamethasone simultaneously with streptozotocin did not affect the enhancement of the intimal PAA.

The hypophysectomy induced in rats significantly increased PAA in the intima of the aorta.

Keywords

Genetically hypercholesterolaemic rats diabetic rats plasminogen activator stanozolol streptozotocin dexamethasone hypophysectomy

Get full access to this article

View all access options for this article.

References

Wilkens

Back

. Fibrinolysis and risk factors of atherosclerotic disease, with special emphasis on diabetes mellitus. Circ Shock 1978; 5: 125–143.

Almér

Pandolfi

Aberg

. The plasminogen activator activity of arteries and veins in diabetes mellitus. Thromb Res 1975; 6: 177–182.

Almér

Pandolfi

. Fibrinolysis and diabetic retinopathy. Diabetes 1976; 25 (Suppl. 2): 807–810.

Kopera

. Miscellaneous uses of anabolic steroids. In: Anabolic-Androgenic Steroids (Ed. Kochakian

). Springer-Verlag, New York, 1976; p 535–625.

Müller

Dinh

Subbiah

MTR

. The characteristics and metabolism of a genetically hypercholesterolemic strain of rats (RICO). Biochim Biophys Acta 1979; 574: 334–343.

Smokovitis

. Sex related fibrinolytic activity in rat tissues. Experientia 1978; 34: 483–484.

Smokovitis

. Regions of constantly increased plasminogen activator activity along the intima of the normal aorta. Haemostasis 1978; 7: 303–319.

Smokovitis

Binder

. The effect of alloxan-induced diabetes on tissue plasminogen activator activity of the rat. Thromb Haemostas 1979; 42: 333 (Abstr.); paper in preparation.

Smokovitis

Auerswald

Binder

. Induced changes in the endothelial plasminogen activator activity of the rat aorta. Fifth Meeting of the International Society of Haematology, Hamburg, 1979; p 48 (Abstr.).

10.

Smokovitis

Binder

. Wirkung des anabolen Steroids Stanozolol auf die fibrinolytische Aktivität bei der Ratte. Blut 1980; 40: 99 (Abstr.).

11.

Samama

. Oral fibrinolytic therapy. In: Haemostasis and Thrombosis. (Eds. Serneri

GG Neri

Prentice

CRM

), Academic Press, New York, 1979; p 271–278.

12.

Reusser

. Mode of action of streptozotocin. J Bact 1971; 105: 580–588.

13.

Bhuyan

Scheidt

Fraser

. Cell cycle phase specificity of antitumor agents. Cancer Res 1972; 32: 398–407.

14.

Rifkin

. Plasminogen activator synthesis by cultured human embryonic lung cells: Characterization of the suppressive effect of corticosteroids. J Cell Physiol 1978; 97: 421–428.